Editorial policy

1. Primary sources only

Clinical, regulatory and chemical facts come from FDA records, trial registries, peer-reviewed journals and reference databases. See the methodology.

2. No dosing or self-treatment content

The site does not publish dosing amounts, schedules, routes, preparation steps or sourcing information for any product. The FDA prescribing information is linked for clinicians and patients.

3. Results, not benefits

Studies are described by what they measured, in whom, and with what limitations. The site does not publish benefit lists or extend a result to populations that were not studied.

4. Approved medicine is kept separate from research material

Clinical findings describe the FDA-approved product. The site does not state or imply that any research-grade material is that product, is approved, or can be used in its place.

5. Commercial separation and disclosure

The site's owner sells research-use-only peptide materials (see ownership). Commercial considerations do not decide what evidence appears or how it is described. Links to the owner appear only in a labelled section, are marked as sponsored, and are never placed on the FDA-status or safety pages. Product links stay switched off unless a recorded legal review approves them.

6. Dated review

Each page shows the date its sources were last checked. Pages are re-checked when FDA labeling changes or when a relevant trial reports results.

7. Corrections

Corrections are made promptly, dated, and noted on the affected page.

8. Automated assistance

Software tools, including AI, help retrieve and organise sources. Every number on the site is traced to a cited primary source, and automated checks block publishing if a citation does not resolve.